利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

30 条记录 (耗时 0.019 秒)

    Automatic traction control for two separately excited motors utilizing a single electronic control
    24.
    发明授权
    Automatic traction control for two separately excited motors utilizing a single electronic control 有权
    使用单个电子控制的两个单独激励的电机的自动牵引力控制

    公开(公告)号：US07956558B2

    公开(公告)日：2011-06-07

    申请号：US12327002

    申请日：2008-12-03

    申请人： Ian Dirk Cull ,  Christian Charles Elie Peyla

    发明人： Ian Dirk Cull ,  Christian Charles Elie Peyla

    IPC分类号： H02P5/00

    CPC分类号： B60W20/00 ,  B60K1/02 ,  B60K6/46 ,  B60L2240/421 ,  B60W10/08 ,  B60W30/18172 ,  B60W2520/10 ,  B60W2520/26 ,  B60W2710/081 ,  Y02T10/6217 ,  Y02T10/642

    摘要： An automatic traction control system is provided for an electric or hybrid-electric vehicle. The automatic traction control system may be used with vehicles using two separately excited motors where the armatures of the motors are connected in series to provide differential control. The automatic traction control system monitors and compares the voltages across the armatures of the two motors. If the voltage differential exceeds a predetermined threshold, it is determined that one of the wheels is spinning and current is diverted from the motor driving the spinning wheel to the motor driving the non-spinning wheel.

    摘要翻译： 为电动或混合动力汽车提供自动牵引力控制系统。 自动牵引力控制系统可以与使用两个单独激励的电动机一起使用，其中电动机的电枢串联连接以提供差动控制。 自动牵引力控制系统监测和比较两个电动机电枢两端的电压。 如果电压差超过规定的阈值，则确定其中一个车轮正在旋转，并且电流从驱动旋转轮的电动机转向驱动非纺车的电动机。

    Device for simulation of the real world by asynchronous and chaotic processing
    25.
    发明申请
    Device for simulation of the real world by asynchronous and chaotic processing 审中-公开
    通过异步和混沌处理仿真真实世界的设备

    公开(公告)号：US20070156381A1

    公开(公告)日：2007-07-05

    申请号：US10586610

    申请日：2005-01-20

    申请人： Jacques Tisseau ,  Fabrice Harrouet ,  Pascal Redou ,  Sebastien Kerdelo ,  Christian Charles

    发明人： Jacques Tisseau ,  Fabrice Harrouet ,  Pascal Redou ,  Sebastien Kerdelo ,  Christian Charles

    IPC分类号： G06F9/45

    CPC分类号： G06F17/5009 ,  G16C20/10

    摘要： A computer to permit programming by active objects in multi-task mode, representative of systems for simulation, includes a device for real world simulation. The device includes an object simulation program for combined evolution of at least some of the active objects, including i) objects of state each containing at least one item of spatial and/or temporal and/or property data defining a current state, ii) interaction objects each containing the definition of at least one of the state objects and at least one function applicable to at least one of the state objects and defining at each point in time the simulated system topology, and iii) a simulation manager operable by sequences on a selection of interaction objects and to activate each interaction object only once for each sequence, according to an order varying in an at least partially random manner from one sequence to the other such as to apply each of the functions thereof to the actual state of each state object designated thereby for the evolution of the state thereof towards a new state.

    摘要翻译： 允许用于多任务模式的活动对象进行编程的计算机，代表用于仿真的系统，包括用于真实世界模拟的装置。 所述设备包括用于至少一些活动对象的组合演化的对象模拟程序，包括i）每个状态对象包含至少一个定义当前状态的空间和/或时间和/或属性数据项，ii）交互 每个对象包含至少一个状态对象的定义和至少一个适用于状态对象中的至少一个的功能，并且在每个时间点定义模拟的系统拓扑，以及iii）模拟管理器， 选择交互对象，并且根据从至少部分随机的方式从一个序列变换到另一个序列的顺序来激活每个交互对象一次，以便将其每个功能应用于每个状态的实际状态 对象被指定为将其状态演变为新的状态。

    2-Cyano indan-1,3-diones
    28.
    发明授权
    2-Cyano indan-1,3-diones 失效
    2-氰基茚满-1,3-二酮

    公开(公告)号：US4012407A

    公开(公告)日：1977-03-15

    申请号：US572226

    申请日：1975-04-28

    申请人： Frank Peter Doyle ,  Barrie Christian Charles Cantello ,  Derek Richard Buckle ,  Harry Smith

    发明人： Frank Peter Doyle ,  Barrie Christian Charles Cantello ,  Derek Richard Buckle ,  Harry Smith

    IPC分类号： C07C49/67 ,  C07C255/45 ,  C07D307/56 ,  C07D311/42 ,  C07C121/75 ,  C07C121/76

    CPC分类号： C07C247/00 ,  C07C49/67 ,  C07C2103/16

    摘要： Pharmaceutical compositions are produced comprising as the active ingredient a compound of the formula ##STR1## or a pharmaceutically acceptable, nontoxic salt thereof or hydrate thereof, wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are each hydrogen, halogen, lower alkyl or lower alkoxy, or any two of the groups R.sub.1, R.sub.2, R.sub.3 and R.sub.4, taken together with the carbon atoms to which they are joined complete a substituted or unsubstituted carbocyclic ring, and X is a bond or an oxygen atom, is combined with a pharmaceutically acceptable, nontoxic inert diluent or carrier. Those compounds wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are not all simultaneously hydrogen are novel.When X is a bond, the compounds may be prepared by reacting an appropriately substituted 3-dyanomethylene phthalide with a base and, thereafter, if desired, converting the compound to a salt. When X is an oxygen atom, the compounds may be prepared by reacting a suitably substituted benzene derivative with an activated carbonyl group having a carbanion of the formula NC--CH--R, wherein R is a carboxylic acid ester group, and thereafter, if desired, converting the compound into a salt.

    摘要翻译： 制备药物组合物，其包含作为活性成分的式IMA化合物或其药学上可接受的无毒盐或其水合物，其中R 1，R 2，R 3和R 4各自为氢，卤素，低级烷基或低级烷氧基，或 R 1，R 2，R 3和R 4中的任何两个与它们连接的碳原子一起形成取代或未取代的碳环，并且X是键或氧原子与药学上可接受的无毒的 惰性稀释剂或载体。 其中R1，R2，R3和R4不全部同时为氢的那些化合物是新的。